The present invention relates to the use of a human protein called phosphatonin, fragments thereof containing an epitope, isolated polynucleotides encoding this protein and fragments thereof, vectors, host cells and antibodies for the preparation of a medicament for the treatment of disorders related to phosphate metabolism and bone mineral loss disorders.